Procept Biorobotics Corp (PRCT) is a Healthcare · Medical Devices company listed on NASDAQ. Price $19.17 (-1.54%), Market cap $1.53B, 52-week low–high $21.71 ~ $65.05.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Financial statements, price targets, institutional (13F) holdings and related news for Procept Biorobotics Corp are updated in real time on BlackAll Trade.
Procept Biorobotics Corp trades at $19.17 (-1.54%). Real-time quotes and charts are available on BlackAll Trade.
Procept Biorobotics Corp has a market cap of about $1.53B.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robot